Biomarkers enable prediction of tacrolimus resistance in patients with severe allergic conjunctivitis

Allergy. 2023 Jan;78(1):319-321. doi: 10.1111/all.15535. Epub 2022 Oct 11.

Naoko Okada^{1

2}, Hiroyuki Yazu^{2

3}, Eisuke Shimizu³, Kazumi Fukagawa³, Satoshi Nunomura⁴, Hirohisa Saito⁵, Kenji Matsumoto⁵, Atsushi Kawaguchi⁶, Kenji Izuhara⁴, Hiroshi Fujishima^{2

3}

¹ Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, Saitama, Japan.
² Department of Ophthalmology, Tsurumi University School of Dental Medicine, Yokohama, Japan.
³ Keio Allergy Center, Keio University School of Medicine, Tokyo, Japan.
⁴ Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan.
⁵ Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development Laboratory, Tokyo, Japan.
⁶ Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga, Japan.

No abstract available

Publication types